GM

Garima Maheshwari

Director Director DIN 07990834
DIN 07990834 First appointment Nov 2017 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Nov 2017
Shareholding value Locked Premium profile

About Garima Maheshwari

Data last updated:

Garima Maheshwari has 8 years in corporate governance. Formerly with 1 company, such as Institute For Prostate Cancer. Engaged in General Business. Contributes to corporate operations.

DIN 07990834
Primary Designation Director
First Appointment 30 Nov 2017
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Institute For Prostate Cancer U85100PN2011NPL141427
Director30 Nov 20172011Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Institute For Prostate Cancer
Premium access

Shareholding and investment profile for Garima Maheshwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Garima Maheshwari

Garima Maheshwari has 8 years in corporate governance. Formerly with 1 company, such as Institute For Prostate Cancer. Engaged in General Business. Contributes to corporate operations.

Garima Maheshwari is associated with 0 companies as a director.

Garima Maheshwari has expertise in General Business.

Garima Maheshwari has 8 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available